News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757 Results
Type
Article (131)
Company Profile (1)
Press Release (625)
Section
Business (241)
Career Advice (1)
Deals (85)
Drug Delivery (1)
Drug Development (187)
FDA (22)
Job Trends (25)
News (458)
Policy (28)
Tag
Academia (3)
Alliances (79)
ALS (1)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (2)
Approvals (15)
Best Places to Work (22)
BIOSECURE Act (1)
Breast cancer (3)
Cancer (9)
Cardiovascular disease (21)
Career advice (1)
CDC (1)
Cell therapy (3)
Clinical research (145)
Compensation (12)
COVID-19 (1)
CRISPR (1)
C-suite (2)
Data (24)
Diagnostics (2)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (53)
Editorial (2)
Events (110)
Executive appointments (3)
FDA (28)
Funding (5)
Gene editing (1)
Gene therapy (7)
GLP-1 (6)
Government (6)
Healthcare (13)
Huntington's disease (1)
Immunology and inflammation (1)
Infectious disease (1)
Inflammatory bowel disease (1)
IPO (75)
Job creations (4)
Job search strategy (1)
JPM (2)
Layoffs (4)
Legal (2)
Longevity (1)
Lung cancer (3)
Manufacturing (1)
MASH (1)
Medical device (5)
Medtech (5)
Mergers & acquisitions (18)
Metabolic disorders (5)
Neurodegenerative disease (2)
Neuroscience (4)
NextGen: Class of 2026 (4)
Non-profit (5)
Obesity (4)
Opinion (2)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (1)
People (90)
Phase 1 (50)
Phase 2 (86)
Phase 3 (58)
Pipeline (12)
Policy (5)
Postmarket research (1)
Preclinical (20)
Radiopharmaceuticals (3)
Rare diseases (19)
Real estate (1)
Regulatory (36)
Research institute (2)
Schizophrenia (1)
Series A (1)
Special edition (1)
Spinal muscular atrophy (1)
Startups (16)
Supply chain (2)
Tariffs (1)
The Weekly (4)
Vaccines (1)
Weight loss (3)
Date
Last 7 days (2)
Last 30 days (13)
Last 365 days (109)
2026 (16)
2025 (101)
2024 (98)
2023 (80)
2022 (98)
2021 (102)
2020 (83)
2019 (70)
2018 (38)
2017 (15)
2016 (8)
2015 (12)
2013 (7)
2012 (12)
2011 (5)
2010 (5)
Location
Asia (51)
Australia (3)
California (108)
Canada (1)
China (2)
Colorado (1)
Europe (52)
Japan (2)
Maryland (1)
Massachusetts (6)
New Jersey (2)
New York (1)
North Carolina (1)
Northern California (83)
Southern California (4)
United States (116)
757 Results for "bridgebio llc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
BridgeBio Shares Pop Again as Phase III Thyroid Drug Exceeds Investor Expectations
Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a genetic thyroid disorder.
October 29, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
CORRECTING and REPLACING -- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 28, 2026
·
1 min read
Press Releases
BridgeBio to Participate in December 2025 Investor Conferences
November 26, 2025
·
1 min read
Press Releases
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 27, 2026
January 28, 2026
·
1 min read
Press Releases
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
January 5, 2026
·
2 min read
Press Releases
BridgeBio to Participate in November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
·
8 min read
Press Releases
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 13, 2026
January 14, 2026
·
1 min read
Press Releases
BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
January 16, 2026
·
8 min read
1 of 76
Next
